Adenomas are the leading cause of primary hyperparathyroidism (pHPT). Throughout the last decades, decreasing size of the adenoma seems to challenge the preoperative work-up and intraoperative management. There are even reports mentioning significant differences between patients from different regions (1), geographic variation between pHPT patients has not been well defined throughout the literature. Although some Western and Eastern studies report large size and/or very high parathyroid hormone levels being involved with increased risk of malignancy (2,3), this has not been supported by others (4) . However, nonclinical factors like the environmental habitat may play a role in the disparities between pHPT patients between regions. To the best of our knowledge, the direct impact of geography on clinical and biochemical data have been neither investigated, nor addressed. Thus, here we aimed to compare the preoperative clinical symptoms and associated conditions and surgical findings in patients with pHPT, living in different geographical regions of the Black Sea, Mediterranean and Anatolia regions in Turkey as well Bulgaria as a whole.
MATERIALS AND METHODS
This is a retrospective study of patients with pHPT treated with parathyroidectomy in 23 centers across Turkey and Bulgaria. Data were collected on all consecutive patients using a standardized template that was finalized and distributed to all centers. The use of these data was consistent with the regulations of the Institutional Review Board of Ege University (Approval number: 16-8.1/36) and received approval. Members of each center performed the collection separately for patients, who had lived for more than 10 years in one of the geographical regions defined below, operated on between January 2010 and September 2012. To account for any regional differences in practice patterns and outcomes, the data were stratified to account for 8 different regions: 1 Bulgaria, 2 Marmara, 3 Turkish Aegean, 4 Turkish Mediterranean, 5 Central Turkey, 6 Turkish Black Sea, 7 Eastern Turkey and 8 South-East Turkey ( Figure  1 ). Baseline demographic, clinical, pathologic and treatment characteristics of the 8 regions were collected and included age, gender, residential data, symptoms, history of fracture, existence of brown tumor, serum total Ca and p levels, serum parathormone (PTH) levels, serum 25-OH vitamin D levels, bone mineral density, size of the resected abnormal parathyroid gland(s) (largest when more than one gland was removed), histology, as well as presence of ectopia, presence of dual adenoma, and MEN-or familial-related disease. Preoperative work-up with ultrasound, scintigraphy, computerized tomography (CT), magnetic resonance imaging (MRI), as well as type of surgery, type of anesthesia and complications, have been questioned. 
Background

RESULTS
Demographics
A total of 694 patients were entered into the database. The median age at presentation was 54 (16-86) with a female preponderance (n=563; 81.1%). The rate of asymptomatic patients was 25% (n=172). Nearly 21% (n=147) of patients had a history of renal stones, 5.2% (n=36) of patients had a history of fracture, while 2.3% (n=16) were reported to have brown tumors. There were 8 (1.2%) patients with Multiple Endocrine Neoplasia Type I or II, or with a familial-related disease. The median preoperative serum PTH level was 232 (70-8068) pg/mL, while serum total Ca level was 11.4 (7.6-16.2) mg/dL. Vitamin D deficiency was shown in 320 (46.1%) patients. Characteristics of patients by region are shown in Table 1 . There were significant regional differences. The rate of existence of preoperative symptoms was highest in the south-eastern part of Turkey (100%) and lowest in Bulgaria and Eastern Turkey (50%; p<0.001). Patients from Bulgaria and the Turkish Black Sea had the highest median serum Ca levels (11.6 and 11.7 mg/ dL, respectively), while South-East Turkey had the lowest (10.9 mg/dL; p<0.001). There was a significantly lower measured p level (2.4 mg/dL) in patients from Eastern Turkey, when compared to other 7 regions (p<0.001).
Localization procedures
Preoperative localization studies were performed in 660 (95.1%) cases. Ultrasound, sestamibi scintigraphy, CT and MRI were carried out in 89.2%, 86.3%, 39.2%, and 40.2% or 619, 599, 272, and 279 patients, respectively. Apart from each, ultrasound and scintigraphy were positive in 519 (83.8%) and 498 (83.1%) cases, respectively. There were no significant regional differences in these characteristics (Table 1) .
Surgery
Overall, 66% (n=458) of patients underwent a conventional bilateral or unilateral approach. The use of the minimally invasive approaches was low (n=236, 34%) throughout the regions. There was a statistically significant difference between patients from the regions with respect to surgical procedure applied (p<0.001) ( Table 1) .
FIG. 1.
Geographic boundaries of the 8 study regions. 1 Bulgaria, 2 Marmara, 3 Turkish Aegean, 4 Turkish Mediterranean, 5 Central Turkey, 6 Turkish Black Sea, 7 Eastern Turkey and 8 South-East Turkey Pathology Eighty-seven percent of patients (n=606) had an adenoma and 90% (n=542) of these had a single adenoma. Hyperplasia was detected in 79 (11.4%) patients and cancer in 9 (1.3%) patients. The median adenoma size was 16 mm (5-65). There was a statistically significant difference in the median values of adenoma size, having a trend towards larger adenomas in region 4, where the median size was 20 mm (7-60) compared to other regions (p=0.001).
Complications, persistence or recurrence
Unadjusted postoperative morbidity following surgery and/or rates of recurrence did not differ between regions (Table 1 ). The rate of persistence was statistically insignificant between regions. Postoperative bleeding occurred in 5 (0.7%) patients. 
DISCUSSION
In this study, we hypothesized that incidence, morphological, clinical and biochemical changes of pHPT vary between geographical regions. The rationale behind this was constructed due to different reports from different regions of the world for pHPT. These differences might be due to regional factors like genetics, environmental factors and life habits. We found that significant parameters, differing between 8 defined geographical regions, were preoperative symptoms, serum total Ca and p levels, and diseased gland size. pHPT is one of the most common endocrine diseases, where the clinical presentation has changed dramatically during the last decades (5,6). The literature on pHPT has previously noted that despite similar pathology, pHPT presents with different clinical characteristics in different populations (1) . The study by Kirdak et al. (1) compared preoperative clinical and metabolic findings in pHPT patients and adenoma size between age-and sexmatched patients from 2 different continents. It was reported that patients from Turkey had higher serum PTH levels, more severe bone disease and larger adenomas. Meanwhile, Turkey, geographically situated both in Asia and Europe Balkans, is a large country with an area of 783.562 km 2 . It borders the Black, Aegean and Mediterranean Seas, and differs widely in geography, including area, population density and the relative contribution of urban and rural areas. For this reason, Turkey has been divided into seven regions, which were originally defined at the First Turkish Geography Congress in 1941. Another country bordering the Black Sea and Turkey is Bulgaria, which is situated in South-East Europe. The land area of Bulgaria, which has its own geographic features, is 110.550 km 2 , which matches the geographical area of Turkey. Until recently, geographic variation has been documented in a variety of health situations and their outcomes (7) (8) (9) (10) . Our data confirm that geographic disparities exist in clinical and biochemical data in patients with pHPT, which is unique to our study. Previously, geographic disparity had been questioned by de Lucia et al. (10) . They reported higher serum Ca levels and lower bone mineral density scores in Italian patients compared to patients from the United States. The data of our study are not surprising based on the knowledge of extraordinary variations in geographic characteristics of the mentioned regions. Although the baseline demographics of patients across regions did not vary widely, the existence of wide regional disparities in pHPT data is striking. We have documented substantial regional differences in the preoperative serum calcium level, with the highest rates observed consistently in the Black Sea region, both in Bulgaria and the Turkish Black Sea region. This finding raises a series of questions that have not been altogether explored; most notably, do the inhabitants of these regions have a main gene polymorphism related to calcium metabolism and therefore experience higher calcium levels more commonly than patients from other regions? Or is there a nutritional impact, since we know that the water of the Black Sea represents special local types with properties that differ from those of sea water in general? (11) It is well known that Black Sea regions receive more rain throughout the year and that desalinated water entry into the Black Sea is much more than that of the Aegean and Mediterranean Seas (12) . Another important characteristic of the Black Sea is that it is the largest water mass with continuous haloclines (13) . These factors affect calcium concentrations of the water content, since desalinated water contains nearly 20 times more calcium when compared to salty water (12) . On the other hand, it might be a matter of debate whether serum calcium levels are affected by geographical variations. There are large volume studies emphasizing increased levels of serum calcium being involved with younger age (14) . This relation will be questioned in our future research. Our study has a number of other salient findings regarding preoperative biochemical changes and sizes of adenomas.
Patients from Eastern Turkey were characterized by the lowest value of serum p level. This distinctive feature in patients living in this region have raised questions regarding whether this is related to dietary factors, since Eastern Turkey has no border with the sea and residents consume less seafood than in other regions. Another salient finding is that pHPT patients from South-East Turkey were all symptomatic. This is quite the contrary of what Adami et al. (5) reported in 2002. According to their paper, the introduction of routine biochemical screening resulted in the increased identification of asymptomatic patients. On the other hand, Wermers et al. (15) documented a decline in the incidence of pHPT after making significant changes in clinical practice and discontinuing serum chemistry panels due to regulatory constraints regarding the use of laboratory panels. Nevertheless, the majority of patients with pHPT were found to remain asymptomatic with mild disease, suggesting routine measurements of calcium. The shift between mild and obvious disease might be related to the difference in regional development status as well, as reported by Kirdak et al. (1) . It will be important to monitor the regions of our study, since the underlying factors influencing these notable findings remain unclear. Collaborative epidemiologic studies covering these regions are warranted. Major shortcomings of the current study come from its retrospective nature and lack of complete data from all regions. Nevertheless, patients were not uniformly distributed throughout the eight regions and the patients were very few in some of them. These are potential confounding factors which are expected from large retrospective studies, but have a negative impact, unfortunately. Secondly, individual center variation may account for some regional variation; a hierarchical model to identify significant underlying center variation as the cause of regional differences is lacking. Thirdly, the present study did not provide any data regarding conversion rates and average follow-up period. Besides, regarding employment for measurement of the main parameters, the study is lacking any cross-calibration between centers. Finally, and maybe most importantly, the variations identified here need to be further investigated to determine whether these changes are attributable to geographic variation by increasing sample size.
In conclusion, our results represented an initial attempt to understand which geographic factors are associated with pHPT and suggested that variations in habitat conditions between geographic regions may affect the clinical and pathological features of pHPT. In addition to raising awareness about the regional disparity of pHPT, our goal with continued research is to characterize further regional differences in pHPT and to determine possible etiologies for these differences. Clinicians should be more vigilant in assessing patients living in the Black Sea region both in Bulgaria and Turkey as well as in South East Turkey for the signs and symptoms of pHPT.
